Search

everythinglearnresearchcommunity

for

Search:↓

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Best hair growth results from combining finasteride and minoxidil.

New treatments for male hypogonadism are effective and should be personalized.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Some Thai plants, especially Carthamus tinctorius, could help prevent hair loss and promote hair growth without adverse effects.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

DHT, a testosterone byproduct, causes male pattern baldness.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Minoxidil lowers blood pressure effectively but may cause unwanted hair growth and other side effects.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.